Significance of Atrial Fibrillation During Acute Myocardial Infarction, and its Current Management: Insights from the GUSTO-3 Trial Cheuk-Kit WongHarvey D. WhiteE. Magnus Ohman OriginalPaper Pages: 201 - 207
Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial Denis Roy OriginalPaper Pages: 208 - 210
Cost Evaluation of Rhythm Control Methods for Atrial Fibrillation: Evidence from CTAF Stanley NattelGerald LumerDenis Roy OriginalPaper Pages: 211 - 214
Azimilide for Atrial Fibrillation: Clinical Trial Results and Implications Edward L.C. PritchettStephen R. Marcello OriginalPaper Pages: 215 - 219
Does Conversion and Prevention of Atrial Fibrillation Enhance Survival in Patients with Left Ventricular Dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) Study Ole Dyg PedersenBente BrendorpChristian Torp-Pedersen OriginalPaper Pages: 220 - 224
Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study Steven N. Singh OriginalPaper Pages: 225 - 228
Beta Blockers Improve Outcome in Patients with Heart Failure and Atrial Fibrillation: U.S. Carvedilol Study Karthik Ramaswamy OriginalPaper Pages: 229 - 232
Beta-Blocker Efficacy According to Heart Rate and Rhythm in Patients with Heart Failure. Commentary on the Cardiac Insufficiency Bisoprolol Study II Analysis Philippe P. Lechat OriginalPaper Pages: 233 - 235
Role of Beta-Blocker Therapy in Heart Failure and Atrial Fibrillation Jeffrey W.H. FungCheuk M. YuJohn E. Sanderson OriginalPaper Pages: 236 - 242
Angiotensin Receptor Blocker as Adjunctive Therapy for Rhythm Control in Atrial Fibrillation: Results of the Irbesartan-Amiodarone Trial Antonio H. MadridCarlos EscobarConcepción Moro OriginalPaper Pages: 243 - 246
Conducting Randomized Trials in the Electrophysiology Laboratory: Lessons from a Randomized Comparison of Recording Methods During Pulmonary Vein Isolation by Segmental Ostial Ablation Hakan OralFred Morady OriginalPaper Pages: 247 - 251
Left Versus Bi-Atrial Intraoperative Saline-Irrigated Radiofrequency Modified Maze Procedure for Atrial Fibrillation Mustafa GudenBelhhan AkpinarSeher Deniz Oztekin OriginalPaper Pages: 252 - 258
Antiarrhythmic Surgery to Cure Atrial Fibrillation—Subgroups and Postoperative Management Thomas DenekeKrishna KhargiBernd Lemke OriginalPaper Pages: 259 - 263
How Should Subgroup Analyses Affect Clinical Practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) John WikstrandHans WedelFinn Waagstein OriginalPaper Pages: 264 - 275
Quality of Life Variables in the Selection of Rate Versus Rhythm Control in Patients with Atrial Fibrillation: Observations from the Canadian Trial of Atrial Fibrillation Paul DorianIqwal Mangat OriginalPaper Pages: 276 - 279
Time to First Recurrence as a Trial Endpoint: Time to Change? Rahul Mehra OriginalPaper Pages: 280 - 284
An Update on Electrical Cardioversion of Atrial Fibrillation Suneet MittalKenneth M. SteinBruce B. Lerman OriginalPaper Pages: 285 - 289
Biphasic Versus Monophasic Shock Waveform for Conversion of Atrial Fibrillation Robert W. RhoRichard L. Page OriginalPaper Pages: 290 - 291
Effect of Electrode Position on the Outcome of Cardioversion Paulus KirchhofMartin BorggrefeGünter Breithardt OriginalPaper Pages: 292 - 296
Amiodarone for the Restoration of Sinus Rhythm in Patients with Atrial Fibrillation Panos E. VardasGeorge E. Kochiadakis OriginalPaper Pages: 297 - 299
Facilitating Electrical Cardioversion of Persistant Atrial Fibrillation by Antiarrhythmic Drugs: Update on Clinical Trial Results Ruey J. Sung OriginalPaper Pages: 300 - 303